Doximity (Doximity) Cash And Cash Equivalents : $123.1 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Doximity Cash And Cash Equivalents?

Doximity's quarterly cash and cash equivalents declined from Jun. 2023 ($306.73 Mil) to Sep. 2023 ($108.40 Mil) but then increased from Sep. 2023 ($108.40 Mil) to Dec. 2023 ($123.09 Mil).

Doximity's annual cash and cash equivalents increased from Mar. 2021 ($66.39 Mil) to Mar. 2022 ($112.81 Mil) and increased from Mar. 2022 ($112.81 Mil) to Mar. 2023 ($158.03 Mil).

Doximity Cash And Cash Equivalents Historical Data

The historical data trend for Doximity's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doximity Cash And Cash Equivalents Chart

Doximity Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

48.43

66.39

112.81

158.03

Doximity Quarterly Data
	Mar19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial												136.45	158.03	306.73	108.40	123.09

Doximity Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Doximity (NYSE:DOCS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Doximity Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Doximity's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Doximity (Doximity) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Doximity Inc (NYSE:DOCS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 3rd Street, Suite 510, San Francisco, CA, USA, 94107

Website

https://www.doximity.com

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Executives

Kira Scherer Wampler	director	C/O DOXIMITY, INC., 500 3RD STREET, SUITE 510, SAN FRANCISCO CA 94107
Craig Overpeck	officer: See Remarks	C/O DOXIMITY, INC., 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Timothy S Cabral	director	C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Anna Bryson	officer: Chief Financial Officer	C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Jeffrey Tangney	director, 10 percent owner, officer: Chief Executive Officer	C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Paul W. Jorgensen	officer: Chief Revenue Officer	500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Gilbert H Kliman	director, 10 percent owner	C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Emergence Capital Partners Ii Lp	10 percent owner	160 BOVET ROAD, SAN MATEO CA 94402
Emergence Equity Partners Ii, L.p.	10 percent owner	160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Gp Partners, Llc	10 percent owner	PIER 5, THE EMBARCADERO, STE 102, SAN FRANCISCO CA 94111-2094
Kevin Spain	director	C/O EMERGENCE CAPITAL, 160 BOVET ROAD, STE. 300, SAN MATEO CA 94402
Emergence Capital Opportunity I, L.p.	10 percent owner	160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Equity Partners Vi, L.p.	10 percent owner	C/O EMERGENCE CAPITAL PARTNERS, 160 BOVET ROAD, SUITE 300 CA SAN MATEO
Regina M. Benjamin	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453